Parathyroid cancer epidemiology and demographics: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
| Line 5: | Line 5: | ||
==Epidemiology and Demographics== | ==Epidemiology and Demographics== | ||
===Prevalence=== | ===Prevalence=== | ||
In developed countries, the prevalence of parathyroid cancer in United States estimated to be .005% | * In developed countries, the prevalence of parathyroid cancer in United States estimated to be .005% | ||
===Incidence=== | ===Incidence=== | ||
* In developed countries, the incidence of parathyroid cancer is 0.015 per 100,000 persons. | * In developed countries, the incidence of parathyroid cancer is 0.015 per 100,000 persons. | ||
| Line 12: | Line 12: | ||
===Gender=== | ===Gender=== | ||
* The ratio of affected women to men is 1:1 in contrast to primary HPT in which there is a significant female predominance (ratio of 3–4:1). | * The ratio of affected women to men is 1:1 in contrast to primary HPT in which there is a significant female predominance (ratio of 3–4:1). | ||
===Developed Countries=== | ===Developed Countries=== | ||
* In Europe, the United States, and Japan, parathyroid carcinoma has been estimated to cause hyperparathyroidism (HPT) in .017% to 5.2% of the cases; however, many series report this entity to account for less than 1% of patients with primary HPT | * In Europe, the United States, and Japan, parathyroid carcinoma has been estimated to cause hyperparathyroidism (HPT) in .017% to 5.2% of the cases; however, many series report this entity to account for less than 1% of patients with primary HPT | ||
==References== | ==References== | ||
{{Reflist|2}} | {{Reflist|2}} | ||
[[Category:Prevalence and incidence]] | [[Category:Prevalence and incidence]] | ||
[[Category:Templates]] | [[Category:Templates]] | ||
Revision as of 16:54, 18 December 2015
|
Parathyroid cancer Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Parathyroid cancer epidemiology and demographics On the Web |
|
American Roentgen Ray Society Images of Parathyroid cancer epidemiology and demographics |
|
Parathyroid cancer epidemiology and demographics in the news |
|
Risk calculators and risk factors for Parathyroid cancer epidemiology and demographics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Ammu Susheela, M.D. [2]
Overview
Epidemiology and Demographics
Prevalence
- In developed countries, the prevalence of parathyroid cancer in United States estimated to be .005%
Incidence
- In developed countries, the incidence of parathyroid cancer is 0.015 per 100,000 persons.
Age
- The median age in most series is between 45 and 51 years.
Gender
- The ratio of affected women to men is 1:1 in contrast to primary HPT in which there is a significant female predominance (ratio of 3–4:1).
Developed Countries
- In Europe, the United States, and Japan, parathyroid carcinoma has been estimated to cause hyperparathyroidism (HPT) in .017% to 5.2% of the cases; however, many series report this entity to account for less than 1% of patients with primary HPT